Evaluation of the safety and efficacy of Continuous Dopaminergic Stimulation by intracerebroventricular administration of anaerobically conserved dopamine in Parkinson's disease at the motor fluctuation stage: Single-center pilot study
This research is looking at a new treatment for people with Parkinson's disease who experience 'motor fluctuations.' This means their movement symptoms, like tremor or stiffness, can change quite suddenly and sometimes become difficult to control. The study will test giving a medicine called dopamine directly into the brain. Dopamine is a natural chemical that's often low in people with Parkinson's. Researchers want to find out if this new method of giving dopamine is safe and if it helps improve movement problems. This is an early-stage study, meaning it's one of the first times this treatment is being tested in people, so researchers are carefully watching for safety and early signs of how well it works.
At a glance
What is this study about?
This study is exploring a new way to help people with Parkinson's disease. Parkinson's happens when certain brain cells that produce a chemical called dopamine stop working properly. Dopamine helps control movement, so when levels are low, people can experience symptoms like tremor, stiffness, and slow movement. Many people with Parkinson's take medicines that help replace dopamine, but sometimes, after a while, these medicines don't last as long, and symptoms can unexpectedly get worse or better. This is what doctors call 'motor fluctuations.'
The researchers in this study are trying a new approach. They are testing a special form of dopamine medicine that is given directly into the brain. The idea is that delivering dopamine this way might keep the levels more steady and help reduce those unpredictable changes in movement symptoms throughout the day. This is an exciting and innovative idea because it aims to provide a continuous supply of the chemical that's missing.
Because this is a very new treatment, this study is a 'Phase I and Phase II' study. This means it's among the very first times this treatment is being given to humans. The main goals are to make sure it's safe and to see if there are any early signs that it could be an effective way to help people with Parkinson's manage their symptoms better. The information gathered from this study will be very important for deciding if this treatment can be studied more widely in the future.
Key takeaways
- This study is testing a new way to treat Parkinson's disease.
- It focuses on people whose movement symptoms change a lot during the day.
- Medicine (dopamine) will be given directly into the brain.
- It's an early safety and effectiveness study.
- Both men and women aged 18+ can apply.
Who may be eligible?
This study is looking for adults aged 18 years and older who have Parkinson's disease. Both men and women are welcome to take part in the research. The key thing is that your Parkinson's symptoms should be at a stage where you experience 'motor fluctuations.' This means your movement abilities, like how easily you can move, might change a lot during the day, sometimes unexpectedly getting worse or better.
The researchers will need to check some other things to make sure the study is a good fit for you and that taking part would be safe. This would involve reviewing your medical history and current health. For example, they'll want to make sure you don't have any other serious health conditions that could make the treatment risky or affect the results of the study.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Have you been diagnosed with Parkinson's disease?
- Do you experience unpredictable changes in your movement symptoms throughout the day?
- Are you able to travel to the study centre for appointments?
What does participation involve?
If you decide to take part, you would receive the study medication, which is a special dopamine medicine given directly into your brain. This would involve a minor surgical procedure to place a small device that delivers the medicine. You would have regular visits to the study centre, where doctors and nurses would monitor your health very closely and check how your Parkinson's symptoms are responding to the treatment. These visits will involve physical examinations, blood tests, and assessments of your movement and daily activities. The researchers will also want to keep in touch with you for a period after the treatment to see how you are doing. The exact number of visits and the total length of your involvement in the study would be explained in detail by the study team.
Potential risks and benefits
Locations (1)
- —UnverifiedFrance
Common questions
What are 'motor fluctuations'?
Motor fluctuations mean that your Parkinson's symptoms, like stiffness or tremor, change un predictably throughout the day, sometimes getting much better or worse.
What is dopamine?
Dopamine is a natural chemical in your brain that helps control movement. People with Parkinson's often don't have enough of it.
How is the medicine given in this study?
The study medicine is given directly into your brain through a minor procedure, rather than taking a pill.
Is this a new treatment?
Yes, this is an early-stage study, meaning it's one of the first times this specific treatment method is being tested in people.
Will I have to stay in hospital?
While you will have regular visits and possibly a short stay for the procedure, the study team will explain all hospital requirements clearly.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.